Surgery drug trial aims to stop Post-Op brain fog
NCT ID NCT05470816
Summary
This large study is testing if a widely used medication called tranexamic acid (TXA) can prevent or reduce delirium—a serious state of sudden confusion—after major gastrointestinal surgery. It involves 826 older adults at high risk for complications, comparing the drug to a placebo. The goal is to see if controlling inflammation can protect the brain and improve recovery after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Health
Melbourne, Victoria, 3181, Australia
Conditions
Explore the condition pages connected to this study.